Euronext N.V.

Regulatory Filings • Dec 7, 2011

CONTACT | Media: +31.20.550.4488 (Amsterdam), +32.2.509.1392 (Brussels) +351.217.900.029 (Lisbon), +44.20.7379.2789 (London) +1.212.656.2411 (New York), +33.1.49.27.11.33 (Paris)

CONTACT | Investor Relations: +1.212.656.5700 (New York) +33.1.49.27.58.60 (Paris)

NYSE Euronext Announces Trading Volumes for November 2011

Global Derivatives ADV Up 1% Year-over-Year; U.S. Equity Options ADV Up 10% European Cash ADV Up 8%; U.S. Cash ADV Down 10%

December 7, 2011 – NYSE Euronext (NYX) today announced trading volumes for its global derivatives and cash equities exchanges for November 2011¹ . Global derivatives average daily volume ("ADV") of 8.3 million contracts in November 2011 increased 0.7% versus the prior year with U.S. equity options increasing 10%. Cash equities ADV in November 2011 were mixed, with European cash trading ADV increasing 8.4% and U.S. cash trading ADV decreasing 9.9% from November 2010 levels.

Highlights

• NYSE Euronext global derivatives ADV in November 2011 of 8.3 million contracts increased 0.7% compared to November 2010 and increased 1.4% from October 2011 levels.
• NYSE Euronext European derivatives products ADV in November 2011 of 4.0 million contracts decreased 9.1% compared to November 2010, but increased 16.4% from October 2011 levels. Excluding Bclear, NYSE Liffe's trade administration and clearing service for OTC products, European derivatives products ADV decreased 2.3% compared to November 2010 and increased 7.3% from October 2011.
• NYSE Euronext U.S. equity options (NYSE Arca and NYSE Amex) ADV of 4.2 million contracts in November 2011 increased 10.0% compared to November 2010 levels, but decreased 9.3% from October 2011. NYSE Euronext's U.S. options exchanges accounted for a record 28.1% of total U.S. consolidated equity options trading in November 2011, up from 24.7% in November 2010 and up from 27.3% recorded in October 2011.
• NYSE Liffe U.S. ADV of approximately 88,500 contracts increased from 19,000 contracts in November 2010, but decreased from 95,600 contracts in October 2011.
• NYSE Euronext European cash products ADV of 1.7 million transactions in November 2011 increased 8.4% compared to November 2010, but decreased 4.1% from October 2011 levels.
• NYSE Euronext U.S. cash products (NYSE, NYSE Arca and NYSE Amex) handled ADV of 2.1 billion shares in November 2011 decreased 9.9% compared to November 2010 and decreased 15.5% compared to October 2011. NYSE Euronext's Tape A matched market share in November 2011 was 34.1%, down from 36.1% in November 2010, but up from 33.9% in October 2011.

¹ All NYSE Euronext derivatives transactions count buy and sell orders together as a single transaction. NYSE Euronext European equities transactions count each buy and sell order as separate transactions, NYSE Euronext U.S. equities transactions count buy and sell orders together as a single transaction.

• There were a total of 22 trading days in Europe and 21 trading days in the U.S. in November 2011 compared to 22 trading days in Europe and 21 trading days in the U.S. in November 2010.

Derivatives Trading

European Derivatives

• NYSE Euronext European derivatives products ADV in November 2011 was 4.0 million futures and options contracts, a decrease of 9.1% from November 2010, but an increase of 16.4% from October 2011.
• The 4.0 million in European derivatives futures and options contracts ADV in November 2011 consisted of 3.1 million contracts executed through our full-service LIFFE CONNECT trading platform and 0.9 million contracts, or 21.5%, executed through Bclear, NYSE Liffe's trade administration and clearing service for OTC products. Excluding Bclear, European derivatives products ADV decreased 2.3% compared to November 2010, but increased 7.3% from October 2011.
• Year-to-date, European derivatives products ADV of 4.6 million contracts was 6.5% below prior year levels. The 4.6 million in futures and options contracts ADV year-todate consisted of 3.4 million contracts executed through LIFFE CONNECT trading platform and 1.1 million contracts, or 24.8%, executed through Bclear.
• Total fixed income products ADV of 2.1 million contracts in November 2011 increased 6.5% from November 2010 and increased 12.4% from October 2011. Year-to-date, total fixed income products ADV of 2.3 million contracts was 1.1% below prior year levels.
• Total equity products (including Bclear) ADV of 1.8 million contracts in November 2011 decreased 23.0% compared to November 2010, but increased 23.4% from October 2011. The 1.8 million contracts in equity products ADV consisted of 1.2 million contracts in individual equity products ADV and 0.5 million contracts in equity index products ADV. The 1.2 million contracts in individual equity products ADV consisted of 0.7 million in futures contracts, which represented a 30.4% decrease compared to November 2010 and 0.5 million in options contracts, which represented a 27.1% decrease compared to November 2010. The average net rate per contract for individual equity futures contracts is significantly lower than other products traded on NYSE Liffe. Year-to-date, total equity products ADV of 2.1 million contracts were 12.6% below prior year levels.
• Total commodities products ADV of 68,000 contracts in November 2011 increased 1.3% compared to November 2010, but decreased 14.1% compared to October 2011. Year-todate, total commodities product ADV of 82,000 contracts was 26.4% above prior year levels.

U.S. Derivatives

• NYSE Euronext U.S. equity options (NYSE Arca and NYSE Amex) ADV of 4.2 million contracts in November 2011 increased 10.0% compared to November 2010, but decreased 9.3% compared to October 2011. Year-to-date, U.S. equity options ADV of 4.4 million contracts was 20.2% above prior year levels.
• Total U.S. consolidated equity options ADV decreased 3.4% to 15.1 million contracts in November 2011 compared to November 2010 and decreased 9.3% compared to October 2011. Year-to-date, U.S. consolidated equity options ADV of 17.0 million contracts was 18.8% above prior year levels.
• NYSE Euronext's U.S. options exchanges accounted for a record 28.1% of the total U.S. consolidated equity options trading in November 2011, up from 24.7% in November 2010 and up from 27.3% in October 2011.

• NYSE Liffe U.S. ADV of approximately 88,500 contracts increased from 19,000 contracts in November 2010, but decreased from 95,600 contracts in October 2011. Year-to-date, U.S. futures and futures options ADV of 80,400 contracts was 387.5% above prior year levels.

Cash Trading

European Cash

• NYSE Euronext European cash products ADV of 1.7 million transactions in November 2011 increased 8.4% compared to November 2010, but decreased 4.1% compared to October 2011.
• Year-to-date, European cash products ADV of 1.7 million transactions was 17.5% above prior year levels.

U.S. Cash

• NYSE Euronext U.S. cash products handled ADV in November 2011 decreased 9.9% to 2.1 billion shares compared to November 2010 and decreased 15.5% from October 2011.
• Year-to-date, U.S. cash products handled ADV was 2.3 billion shares, down 12.3% from prior year levels.
• NYSE Euronext's Tape A matched market share in November 2011 was 34.1%, down from 36.1% in November 2010, but up from 33.9% in October 2011.

Exchange Traded Funds

• NYSE Euronext U.S. matched exchange-traded funds ADV (included in volumes for Tape B and Tape C) of 320 million shares in November 2011 increased 1.6% compared to November 2010, but decreased 20.1% compared to October 2011.
• Year-to-date, NYSE Euronext U.S. matched exchange-traded funds ADV of 331 million shares was 3.8% below prior year levels.

Please click here for the Monthly Transaction Activity Data Table.

About NYSE Euronext

NYSE Euronext (NYX) is a leading global operator of financial markets and provider of innovative trading technologies. The company's exchanges in Europe and the United States trade equities, futures, options, fixed-income and exchange-traded products. With approximately 8,000 listed issues (excluding European Structured Products), NYSE Euronext's equities markets – the New York Stock Exchange, NYSE Euronext, NYSE Amex, NYSE Alternext and NYSE Arca – represent one-third of the world's equities trading, the most liquidity of any global exchange group. NYSE Euronext also operates NYSE Liffe, one of the leading European derivatives businesses and the world's second-largest derivatives business by value of trading. The company offers comprehensive commercial technology, connectivity and market data products and services through NYSE Technologies. NYSE Euronext is in the S&P 500 index, and is the only exchange operator in the Fortune 500. For more information, please visit: http://www.nyx.com.

Safe Harbour Statement

In connection with the proposed business combination transaction between NYSE Euronext and Deutsche Boerse AG, Alpha Beta Netherlands Holding N.V. ("Holding"), a newly formed holding company, filed, and the SEC declared effective on May 3, 2011, a Registration Statement on Form F-4 with the U.S. Securities and Exchange Commission ("SEC") that includes (1) a proxy statement of NYSE Euronext that also constitutes a prospectus for Holding used in connection with NYSE Euronext special meeting of stockholders held on July 7, 2011 and (2) an offering prospectus used in connection with Holding's offer to acquire Deutsche Boerse AG

shares held by U.S. holders. Holding has also filed an offer document with the German Federal Financial Supervisory Authority (Bundesanstalt fuer Finanzdienstleistungsaufsicht) ("BaFin"), which was approved by the BaFin for publication pursuant to the German Takeover Act (Wertpapiererwerbs-und Übernahmegesetz), and was published on May 4, 2011.

Investors and security holders are urged to read the definitive proxy statement/prospectus, the offering prospectus, the offer document, as amended, and published additional accompanying information in connection with the exchange offer regarding the proposed business combination transaction because they contain important information. You may obtain a free copy of the definitive proxy statement/prospectus, the offering prospectus and other related documents filed by NYSE Euronext and Holding with the SEC on the SEC's website at www.sec.gov. The definitive proxy statement/prospectus and other documents relating thereto may also be obtained for free by accessing NYSE Euronext's website at www.nyse.com. The offer document, as amended, and published additional accompanying information in connection with the exchange offer are available at Holding's website at www.global-exchange-operator.com.

This document is neither an offer to purchase nor a solicitation of an offer to sell shares of Holding, Deutsche Boerse AG or NYSE Euronext. The final terms and further provisions regarding the public offer are disclosed in the offer document that has been approved by the BaFin and in documents that have been filed with the SEC.

No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the U.S. Securities Act of 1933, as amended, and applicable European regulations. The exchange offer and the exchange offer document as amended, shall not constitute an issuance, publication or public advertising of an offer pursuant to laws and regulations of jurisdictions other than those of Germany, United Kingdom of Great Britain and Northern Ireland and the United States of America. The relevant final terms of the proposed business combination transaction will be disclosed in the information documents reviewed by the competent European market authorities.

Subject to certain exceptions, in particular with respect to qualified institutional investors (tekikaku kikan toshika) as defined in Article 2 para. 3 (i) of the Financial Instruments and Exchange Act of Japan (Law No. 25 of 1948, as amended), the exchange offer will not be made directly or indirectly in or into Japan, or by use of the mails or by any means or instrumentality (including without limitation, facsimile transmission, telephone and the internet) of interstate or foreign commerce or any facility of a national securities exchange of Japan. Accordingly, copies of this announcement or any accompanying documents may not be, directly or indirectly, mailed or otherwise distributed, forwarded or transmitted in, into or from Japan.

The shares of Holding have not been, and will not be, registered under the applicable securities laws of Japan. Accordingly, subject to certain exceptions, in particular with respect to qualified institutional investors (tekikaku kikan toshika) as defined in Article 2 para. 3 (i) of the Financial Instruments and Exchange Act of Japan (Law No. 25 of 1948, as amended), the shares of Holding may not be offered or sold within Japan, or to or for the account or benefit of any person in Japan.

	Average Daily Volume			Total Volume			Average Daily Volume		Total Volume
(Unaudited; contracts in thousands)	Nov-11	Nov-10	% Chg	Nov-11	Nov-10	% Chg	YTD 2011	% Chg vs. YTD 2010	YTD 2011	% Chg vs. YTD 2010
Number of Trading Days - European Markets Number of Trading Days - U.S. Markets	22 21	22 21		22 21	22 21		236 231		236 231
European Derivatives Products	3,974	4,373	-9.1%	87,432	96,199	-9.1%	4,560	-6.5%	1,076,252	-6.1%
of which Bclear	855		1,180 -27.5%	18,811		25,956 -27.5%	1,132	-16.9%	267,197	-16.5%
Total Fixed Income Products	2,136	2,006	6.5%	46,998	44,137	6.5%	2,330	-1.1%	549,865	-0.7%
Short Term Interest Rate Products Medium and Long Term Interest Rate Products 1	1,963 173	1,834 172	7.0% 0.6%	43,195 3,803	40,355 3,781	7.0% 0.6%	2,186 144	-2.2% 18.4%	515,916 33,948	-1.8% 18.9%
Total Equity Products 2	1,770		2,299 -23.0%	38,930		50,578 -23.0%	2,149	-12.6%	507,081	-12.2%
Individual Equity Products	1,240		1,747 -29.0%	27,275		38,437 -29.0%	1,563	-15.5%	368,895	-15.2%
Futures Options	706 533		1,015 -30.4% 732 -27.1%	15,539 11,737		22,338 -30.4% 16,099 -27.1%	967 596	-16.6% -13.8%	228,274 140,621	-16.2% -13.4%
Equity Index Products	530	552	-4.0%	11,654	12,140	-4.0%	586	-3.6%	138,186	-3.2%
of which Bclear	855		1,180 -27.5%	18,811		25,956 -27.5%	1,132	-16.9%	267,197	-16.5%
Individual Equity Products Futures	787 681		1,100 -28.4% 1,008 -32.4%	17,320 14,987		24,199 -28.4% 22,173 -32.4%	1,053 950	-17.0% -17.7%	248,399 224,259	-16.6% -17.4%
Options	106	92	15.2%	2,333	2,025	15.2%	102	-9.6%	24,139	-9.2%
Equity Index Products	68	80	-15.2%	1,490		1,757 -15.2%	80	-15.5%	18,799	-15.2%
Commodity Products	68	67	1.3%	1,504	1,484	1.3%	82	26.4%	19,307	26.9%
U.S. Derivatives Products
Equity Options 3
NYSE Euronext Options Contracts Total Consolidated Options Contracts	4,244 15,119	3,860 15,657	10.0% -3.4%	89,127 317,497 328,798	81,057	10.0% -3.4%	4,448 16,995	20.2% 18.8%	1,027,537 3,925,903	20.7% 19.3%
NYSE Group Share of Total	28.1%	24.7%		28.1%	24.7%		26.2%	0.3%	26.2%	0.3%
NYSE Liffe U.S.
Futures and Futures Options Volume*	88.5		19.0 366.3%	1,947		399 388.5%	80.4	387.5%	19,055.2	402.4%
European Cash Products (trades in thousands)	1,671	1,541	8.4%	36,756	33,903	8.4%	1,744	17.5%	411,623	18.0%
Equities Exchange-Traded Funds	1,602 22	1,473	8.7% 19 14.3%	35,243 483	32,416	8.7% 423 14.3%	1,676 21	17.6% 17.0%	395,494 4,944	18.1% 17.5%
Structured Products	42	42	-1.3%	922	934	-1.3%	42	16.7%	10,007	17.2%
Bonds	5		6 -16.7%	108		129 -16.7%	5	-13.2%	1,177	-12.8%
U.S. Cash Products (shares in millions) 5	2,108	2,339	-9.9%	44,272 49,129		-9.9%	2,327	-12.3%	537,541	-11.9%
NYSE Listed (Tape A) Issues 4
Handled Volume 5 Matched Volume 6	1,466	1,671	-12.3%	30,790	35,101	-12.3%	1,637	-14.8%	378,088	-14.4%
Total NYSE Listed Consolidated Volume	1,391 4,083	1,583 4,391	-12.1% -7.0%	29,219 85,749	33,244 92,209	-12.1% -7.0%	1,552 4,438	-13.9% -10.3%	358,418 1,025,181	-13.5% -9.9%
Share of Total Consolidated Volume
Handled Volume 5	35.9%	38.1%	-2.2%	35.9%	38.1%	-2.2%	36.9%	-1.9%	36.9%	-1.9%
Matched Volume 6	34.1%	36.1%	-2.0%	34.1%	36.1%	-2.0%	35.0%	-1.5%	35.0%	-1.5%
NYSE Arca & Amex (Tape B) Listed Issues
Handled Volume 5 Matched Volume 6	368 333	366 332	0.6% 0.4%	7,738 6,988	7,694 6,963	0.6% 0.4%	389 350	-1.9% -1.7%	89,848 80,943	-1.5% -1.3%
Total NYSE Arca & Amex Listed Consolidated Volume	1,422	1,357	4.8%	29,868	28,496	4.8%	1,501	0.5%	346,829	1.0%
Share of Total Consolidated Volume
Handled Volume 5 Matched Volume 6	25.9% 23.4%	27.0% 24.4%	-1.1% -1.0%	25.9% 23.4%	27.0% 24.4%	-1.1% -1.0%	25.9% 23.3%	-0.7% -0.5%	25.9% 23.3%	-0.7% -0.5%
Nasdaq Listed (Tape C) Issues
Handled Volume 5	274	302	-9.3%	5,744	6,334	-9.3%	301	-10.2%	69,605	-9.8%
Matched Volume 6	236	257	-8.0%	4,963	5,394	-8.0%	260	-8.3%	59,963	-7.9%
Total Nasdaq Listed Consolidated Volume	1,857	1,984	-6.4%	38,997	41,665	-6.4%	2,058	-8.1%	475,511	-7.7%
Share of Total Consolidated Volume Handled Volume 5	14.7%	15.2%	-0.5%	14.7%	15.2%	-0.5%	14.6%	-0.3%	14.6%	-0.3%
Matched Volume 6	12.7%	12.9%	-0.2%	12.7%	12.9%	-0.2%	12.6%	0.0%	12.6%	0.0%
Exchange-Traded Funds 5,7
Handled Volume 5	355	348	1.9%	7,453	7,312	1.9%	367	-3.8%	84,887	-3.4%
Matched Volume 6	320	315	1.6%	6,728	6,624	1.6%	331	-3.8%	76,430	-3.4%
Total ETF Consolidated Volume	1,400	1,303	7.5%	29,409	27,361	7.5%	1,446	-1.8%	333,924	-1.4%
Share of Total Consolidated Volume Handled Volume 5	25.3%	26.7%	-1.4%	25.3%	26.7%	-1.4%	25.4%	-0.5%	25.4%	-0.5%
Matched Volume 6	22.9%	24.2%	-1.3%	22.9%	24.2%	-1.3%	22.9%	-0.5%	22.9%	-0.5%

7 Data included in previously identified categories.

* ADVs calculated with the appropriate number of NYSE Liffe U.S. trading.

Source: NYSE Euronext, Options Clearing Corporation and Consolidated Tape as reported for equity securities.

All trading activity is single-counted, except European cash trading which is double counted to include both buys and sells.

5 Represents the total number of shares of equity securities and ETFs internally matched on the NYSE Group's exchanges or routed to and executed at an external market center. NYSE Arca routing includes odd-lots.

4 Includes all volume executed in NYSE Group crossing sessions.

NYSE Euronext Monthly Volume Summary

6 Represents the total number of shares of equity securities and ETFs executed on the NYSE Group's exchanges.

1 Data includes currency products.

2 Includes Bclear trading Includes all trading activities for Bclear, NYSE Liffe's clearing service for wholesale derivatives.

3 Includes trading in U.S. equity options contracts, not equity-index options.